Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation. (Q51797175)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 May 2007

Language	Label	Description	Also known as
English	Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation.	scientific article published on 26 May 2007

Statements

scholarly article

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation. (English)

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

4

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

author name string

Francesca Novi

1

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

Mark J Millan

2

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

Giovanni U Corsini

3

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

language of work or name

0 references

publication date

26 May 2007

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

Journal of Neurochemistry

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

102

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

4

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

1410-1424

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Domain swapping in the human histamine H1 receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Agonist occupation of an alpha2A-adrenoreceptor-Gi1alpha fusion protein results in activation of both receptor-linked and endogenous Gi proteins. Comparisons of their contributions to GTPase activity and signal transduction and analysis of receptor-

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Basal signaling activity of human dopamine D2L receptor demonstrated with an ecdysone-inducible mammalian expression system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D(2)-receptor and serotonin 5-HT(1A)-receptor affinities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Effects of reciprocal chimeras between the C-terminal portion of third intracellular loops of the human dopamine D2 and D3 receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Mechanism of new antipsychotic medications: occupancy is not just antagonism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Strategy for modulation of central dopamine transmission based on the partial agonist concept in schizophrenia therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

The ants go marching two by two: oligomeric structure of G-protein-coupled receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Dopamine D3 receptor antagonists as therapeutic agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Aripiprazole: pharmacology, efficacy, safety and tolerability

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Dopamine partial agonists: a new class of antipsychotic

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Serotonin receptors: their key role in drugs to treat schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Cooperative conformational changes in a G-protein-coupled receptor dimer, the leukotriene B(4) receptor BLT1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Crystal structure of rhodopsin: A G protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Atypical antipsychotics: are some more atypical than others?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

D2/D3 dopamine receptor heterodimers exhibit unique functional properties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Functional selectivity, ligand-directed trafficking, conformation-specific agonism: what's in a name?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl- d -aspartate receptor activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

D3 dopamine receptor mRNA is widely expressed in the human brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Rhodopsin dimers in native disc membranes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04660.X

21 January 2018

Identifiers

10.1111/J.1471-4159.2007.04660.X

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/17532788

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51797175&oldid=942483670"